As our clinical trials progress with increasing global footprint, our clinical-stage products have also received continuous recognition from our partners as we are granted with impressive payment or are entitled to co-developed late-stage products with Nasdaq-listed partners. The globalized efforts of clinical research and business development will also prepare GenFleet for a globalized strategy of commercialization in advance.
Leading-edge Pipeline
R&D Staff
R&D Functions
Staff with Master or Doctoral Degrees
Manufacturing Sites
GenFleet sets up a cutting-edge pipeline of innovative therapies with a view to our prospective and highly differentiated strategy: we basically choose biological targets or pathways that have not achieved proof of concept in clinical trials across the globe. Our proprietary and fully integrated R&D platform and diversified co-development programs promote the company's continuous innovative drug discovery and clinical progress.
As our clinical trials progress with increasing global footprint, our clinical-stage products have also received continuous recognition from our partners home and abroad. The globalized efforts of clinical research and business development will also prepare GenFleet for a globalized strategy of commercialization in advance.
-874.jpg)
-592.jpg)
-989.jpg)
